[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Amiodarone.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be decreased when combined with Amiodarone.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Amiodarone.]
[L04AA27, fingolimod, Fingolimod may increase the arrhythmogenic activities of Amiodarone.]
[M03AB01, succinylcholine, The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Amiodarone.]
[J01EC02, sulfadiazine, The metabolism of Sulfadiazine can be decreased when combined with Amiodarone.]
[J01EC01, sulfamethoxazole, The metabolism of Amiodarone can be decreased when combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Sulfinpyrazone can be decreased when combined with Amiodarone.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Amiodarone.]
[M01AB02, sulindac, The risk or severity of hyperkalemia can be increased when Sulindac is combined with Amiodarone.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Amiodarone.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Amiodarone.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Glymidine.]
[M01AX04, apazone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Azapropazone.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be increased when it is combined with Amiodarone.]
[N06DA01, tacrine, The metabolism of Tacrine can be decreased when combined with Amiodarone.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Amiodarone.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Amiodarone.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Amiodarone.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Amiodarone.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Amiodarone.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Tetrabenazine.]
[S03AA02, tetracycline, The metabolism of Tetracycline can be decreased when combined with Amiodarone.]
[N05AE05, lurasidone, The metabolism of Lurasidone can be decreased when combined with Amiodarone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Amiodarone.]
[N04BC07, apomorphine, The metabolism of Amiodarone can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, The risk or severity of peripheral neuropathy can be increased when Thalidomide is combined with Amiodarone.]
[R03DA07, theobromine, The serum concentration of Theobromine can be increased when it is combined with Amiodarone.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Amiodarone.]
[P02CA02, thiabendazole, The metabolism of Thiabendazole can be decreased when combined with Amiodarone.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Amiodarone.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Amiodarone.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Amiodarone.]
[N05AB08, thioproperazine, The risk or severity of hypotension can be increased when Thioproperazine is combined with Amiodarone.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Amiodarone.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Amiodarone.]
[C01BB04, aprindine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Aprindine.]
[B01AC05, ticlopidine, The metabolism of Amiodarone can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The therapeutic efficacy of Timolol can be increased when used in combination with Amiodarone.]
[P01AB02, tinidazole, The metabolism of Tinidazole can be decreased when combined with Amiodarone.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Amiodarone.]
[M02AX02, tolazoline, The risk or severity of hypotension can be increased when Tolazoline is combined with Amiodarone.]
[V04CA01, tolbutamide, The metabolism of Amiodarone can be decreased when combined with Tolbutamide.]
[M02AA21, tolmetin, The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Amiodarone.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Amiodarone.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the orthostatic hypotensive activities of Amiodarone.]
[N06AX05, trazodone, Amiodarone may increase the QTc-prolonging activities of Trazodone.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Amiodarone.]
[S01BA05, triamcinolone, The metabolism of Triamcinolone can be decreased when combined with Amiodarone.]
[C03DB02, triamterene, The metabolism of Triamterene can be decreased when combined with Amiodarone.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Amiodarone.]
[C03AA06, trichlormethiazide, Amiodarone may increase the hypotensive activities of Trichlormethiazide.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be decreased when combined with Amiodarone.]
[R03BA07, mometasone, The metabolism of Amiodarone can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Trimebutine.]
[S01ED04, metipranolol, The risk or severity of adverse effects can be increased when Amiodarone is combined with Metipranolol.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Amiodarone.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Amiodarone is combined with Trimethadione.]
[C02BA01, trimethaphan, Amiodarone may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Amiodarone.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Amiodarone.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Amiodarone.]
[J01FA08, troleandomycin, The metabolism of Amiodarone can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Amiodarone.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Amiodarone is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, Amiodarone may increase the neuromuscular blocking activities of Tubocurarine.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Amiodarone.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Amiodarone.]
[L02BX03, abiraterone, The metabolism of Abiraterone can be decreased when combined with Amiodarone.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Amiodarone.]
[J05AP03, boceprevir, The serum concentration of Amiodarone can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Amiodarone can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be increased when it is combined with Amiodarone.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Amiodarone.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Amiodarone.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be decreased when combined with Amiodarone.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Amiodarone.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Amiodarone is combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Amiodarone can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Amiodarone.]
[C04AX07, vincamine, Amiodarone may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Amiodarone.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Amiodarone.]
[A11HA03, vitamin E, The metabolism of Vitamin E can be decreased when combined with Amiodarone.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Amiodarone is combined with Warfarin.]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be decreased when combined with Amiodarone.]
[N01AX15, xenon, Amiodarone may increase the cardiodepressant activities of Xenon.]
[C03BA10, xipamide, Amiodarone may increase the hypotensive activities of Xipamide.]
[J05AF01, zidovudine, The metabolism of Zidovudine can be decreased when combined with Amiodarone.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Amiodarone.]
[J05AE02, indinavir, The serum concentration of Amiodarone can be increased when it is combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Amiodarone.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Amiodarone.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Amiodarone.]
[L01ED01, crizotinib, The metabolism of Amiodarone can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Amiodarone can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Rabeprazole can be decreased when combined with Amiodarone.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Amiodarone.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Trovafloxacin is combined with Amiodarone.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Amiodarone.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Amiodarone.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Amiodarone.]
[G04BD07, tolterodine, The serum concentration of Tolterodine can be increased when it is combined with Amiodarone.]
[C07AB03, atenolol, The therapeutic efficacy of Atenolol can be increased when used in combination with Amiodarone.]
[J02AC03, voriconazole, The metabolism of Amiodarone can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, Amiodarone may increase the neuromuscular blocking activities of Atracurium.]
[S01FA01, atropine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Atropine.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Amiodarone.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Amiodarone.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Amiodarone.]
[H02AB11, prednylidene, The metabolism of Prednylidene can be decreased when combined with Amiodarone.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Amiodarone.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Amiodarone.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Amiodarone.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Amiodarone.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Amiodarone.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be decreased when combined with Amiodarone.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be increased when it is combined with Amiodarone.]
[V03AX03, cobicistat, The metabolism of Amiodarone can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Amiodarone can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Amiodarone can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Amiodarone.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Amiodarone.]
[L04AA31, teriflunomide, The metabolism of Amiodarone can be decreased when combined with Teriflunomide.]
[A02AA05, magnesium silicate, The risk or severity of hypotension can be increased when Magnesium silicate is combined with Amiodarone.]
[H02AA01, aldosterone, The metabolism of Aldosterone can be decreased when combined with Amiodarone.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Amiodarone.]
[N05CA04, barbital, The metabolism of Amiodarone can be increased when combined with Barbital.]
[C01AA01, acetyldigitoxin, The serum concentration of Acetyldigitoxin can be increased when it is combined with Amiodarone.]
[J05AE04, nelfinavir, The risk or severity of Cardiac Arrhythmia can be increased when Nelfinavir is combined with Amiodarone.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Amiodarone.]
[N04BD02, rasagiline, The serum concentration of Rasagiline can be increased when it is combined with Amiodarone.]
[C08CA13, lercanidipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Amiodarone.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Amiodarone.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Amiodarone.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Amiodarone.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Amiodarone.]
[N01AA01, ethyl ether, Amiodarone may increase the cardiodepressant activities of Diethyl ether.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Amiodarone.]
[H01CB05, pasireotide, The metabolism of Amiodarone can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Amiodarone.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Amiodarone.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Amiodarone.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Amiodarone.]
[J04AK05, bedaquiline, The metabolism of Bedaquiline can be decreased when combined with Amiodarone.]
[C04AX11, bencyclane, The risk or severity of adverse effects can be increased when Amiodarone is combined with Bencyclane.]
[C10AX11, mipomersen, Amiodarone may increase the hepatotoxic activities of Mipomersen.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Amiodarone.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Amiodarone can be increased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Amiodarone.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Amiodarone.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Amiodarone.]
[N02BA10, benorilate, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Benorilate.]
[A10BK02, canagliflozin, The metabolism of Canagliflozin can be decreased when combined with Amiodarone.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Amiodarone.]
[A12CC09, magnesium orotate, The risk or severity of hypotension can be increased when Magnesium orotate is combined with Amiodarone.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Amiodarone.]
[A06AX06, tegaserod, The metabolism of Amiodarone can be decreased when combined with Tegaserod.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Amiodarone.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Amiodarone.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Pramlintide.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Amiodarone.]
[C10AC04, colesevelam, The excretion of Amiodarone can be increased when combined with Colesevelam.]
[L04AA18, everolimus, The serum concentration of Everolimus can be increased when it is combined with Amiodarone.]
[A12CC05, magnesium aspartate, The risk or severity of hypotension can be increased when Magnesium aspartate is combined with Amiodarone.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Amiodarone.]
[L01EC02, dabrafenib, The serum concentration of Dabrafenib can be increased when it is combined with Amiodarone.]
[R02AX03, benzydamine, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Benzydamine.]
[L01EE01, trametinib, The metabolism of Amiodarone can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The metabolism of Amiodarone can be decreased when combined with Benzyl alcohol.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Amiodarone.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Amiodarone.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be increased when it is combined with Amiodarone.]
[C08EA02, bepridil, The risk or severity of adverse effects can be increased when Amiodarone is combined with Bepridil.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Amiodarone.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Lixisenatide.]
[C02KX04, macitentan, The metabolism of Macitentan can be decreased when combined with Amiodarone.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Amiodarone.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Amiodarone.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be decreased when combined with Amiodarone.]
[N03AF04, eslicarbazepine, The metabolism of Amiodarone can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Simeprevir can be decreased when combined with Amiodarone.]
[J05AP08, sofosbuvir, Sofosbuvir may increase the bradycardic activities of Amiodarone.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Amiodarone.]
[C07AB04, acebutolol, The therapeutic efficacy of Acebutolol can be increased when used in combination with Amiodarone.]
[N05CH03, tasimelteon, The serum concentration of Tasimelteon can be increased when it is combined with Amiodarone.]
[A16AA07, metreleptin, The metabolism of Amiodarone can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Apremilast can be decreased when combined with Amiodarone.]
[L02BG02, formestane, The metabolism of Amiodarone can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Betamethasone can be decreased when combined with Amiodarone.]
[S01ED02, betaxolol, The therapeutic efficacy of Betaxolol can be increased when used in combination with Amiodarone.]
[C02CC01, bethanidine, Amiodarone may increase the hypotensive activities of Bethanidine.]
[C10AB02, bezafibrate, The metabolism of Bezafibrate can be decreased when combined with Amiodarone.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Amiodarone can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, Amiodarone may increase the bradycardic activities of Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Amiodarone.]
[A03BA03, hyoscyamine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Hyoscyamine.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Amiodarone is combined with Acenocoumarol.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Amiodarone.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Amiodarone.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Empagliflozin.]
[R03AC19, olodaterol, The metabolism of Amiodarone can be decreased when combined with Olodaterol.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Amiodarone.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Amiodarone.]
[J01XA05, oritavancin, The metabolism of Amiodarone can be increased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of hypotension can be increased when Acepromazine is combined with Amiodarone.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Amiodarone.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Dulaglutide.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Amiodarone.]
[A11HA08, tocophersolan, The metabolism of Tocofersolan can be decreased when combined with Amiodarone.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Amiodarone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Amiodarone.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Amiodarone.]
[S03AA06, gentamicin, The serum concentration of Gentamicin can be increased when it is combined with Amiodarone.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Amiodarone.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Amiodarone.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Amiodarone.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Amiodarone.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Amiodarone.]
[L04AC10, secukinumab, The metabolism of Amiodarone can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Amiodarone.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Amiodarone.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Amiodarone.]
[J05AP07, daclatasvir, Daclatasvir may increase the bradycardic activities of Amiodarone.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Amiodarone.]
[C01EB17, ivabradine, Amiodarone may increase the bradycardic activities of Ivabradine.]
[J05AP06, asunaprevir, The serum concentration of Amiodarone can be increased when it is combined with Asunaprevir.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Amiodarone.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Amiodarone.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be decreased when combined with Amiodarone.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be decreased when combined with Amiodarone.]
[A06AD03, magnesium peroxide, The risk or severity of hypotension can be increased when Magnesium peroxide is combined with Amiodarone.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be decreased when combined with Amiodarone.]
[A10BF01, acarbose, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Acarbose.]
[M02AA25, aceclofenac, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Acemetacin.]
[S01EC01, acetazolamide, The metabolism of Amiodarone can be decreased when combined with Acetazolamide.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin degludec.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Acipimox.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Amiodarone.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Amiodarone.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Amiodarone.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Amiodarone.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Amiodarone.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Amiodarone.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Amiodarone.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Amiodarone.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Amiodarone.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Amiodarone.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Amiodarone.]
[M04AB05, lesinurad, The metabolism of Amiodarone can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Amiodarone.]
[J05AP11, grazoprevir, The metabolism of Grazoprevir can be decreased when combined with Amiodarone.]
[N05CA05, aprobarbital, The metabolism of Amiodarone can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Alminoprofen.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Amiodarone.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Amiodarone.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Amiodarone.]
[N04BC01, bromocriptine, The serum concentration of Bromocriptine can be increased when it is combined with Amiodarone.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Amiodarone.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be decreased when combined with Amiodarone.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Amiodarone.]
[C03CA02, bumetanide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Amiodarone.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Amiodarone.]
[C07AA19, bupranolol, The therapeutic efficacy of Bupranolol can be increased when used in combination with Amiodarone.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Amiodarone.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Amiodarone.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Amiodarone.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Amiodarone.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, Rivastigmine may increase the bradycardic activities of Amiodarone.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Amiodarone.]
[M02AA03, clofezone, The metabolism of Rabeprazole can be decreased when combined with Amiodarone.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Amiodarone.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Amiodarone.]
[L01XK03, rucaparib, The metabolism of Amiodarone can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Amiodarone.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Amiodarone.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Amiodarone.]
[A07EC04, balsalazide, The risk or severity of hyperkalemia can be increased when Balsalazide is combined with Amiodarone.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be increased when it is combined with Amiodarone.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Amiodarone.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Amiodarone.]
[N06BC01, caffeine, The serum concentration of Caffeine can be increased when it is combined with Amiodarone.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Amiodarone.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Benfluorex.]
[D05AX03, calcitriol, The metabolism of Calcitriol can be decreased when combined with Amiodarone.]
[G04BA03, calcium chloride, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium chloride.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Amiodarone.]
[J05AE09, tipranavir, The metabolism of Amiodarone can be decreased when combined with Tipranavir.]
[D11AX03, calcium gluconate, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium gluconate.]
[H03BA03, benzylthiouracil, The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Amiodarone.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Amiodarone.]
[L04AB02, infliximab, The metabolism of Amiodarone can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Amiodarone.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Amiodarone.]
[N04BD03, safinamide, The metabolism of Safinamide can be decreased when combined with Amiodarone.]
[L04AC14, sarilumab, The metabolism of Amiodarone can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Amiodarone.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Amiodarone.]
[D01AC10, bifonazole, The metabolism of Amiodarone can be decreased when combined with Bifonazole.]
[P03AC02, bioallethrin, The risk or severity of adverse effects can be increased when Amiodarone is combined with Bioallethrin.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Amiodarone.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Amiodarone.]
[L01EH02, neratinib, The serum concentration of Neratinib can be increased when it is combined with Amiodarone.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Amiodarone.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Amiodarone.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Amiodarone.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Amiodarone.]
[C07AB07, bisoprolol, The therapeutic efficacy of Bisoprolol can be increased when used in combination with Amiodarone.]
[J05AG03, efavirenz, The serum concentration of Amiodarone can be decreased when it is combined with Efavirenz.]
[C07AA17, bopindolol, The therapeutic efficacy of Bopindolol can be increased when used in combination with Amiodarone.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nesiritide.]
[N05CD09, brotizolam, The metabolism of Brotizolam can be decreased when combined with Amiodarone.]
[C03DA03, canrenone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Canrenone.]
[R03BA02, budesonide, The metabolism of Budesonide can be decreased when combined with Amiodarone.]
[M01AB07, bumadizone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Amiodarone.]
[J05AX18, letermovir, The metabolism of Amiodarone can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Amiodarone.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Amiodarone.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Semaglutide.]
[N01BX04, capsaicin, The metabolism of Amiodarone can be decreased when combined with Capsaicin.]
[A10BK04, ertugliflozin, The serum concentration of Ertugliflozin can be increased when it is combined with Amiodarone.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Amiodarone.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Captopril.]
[V04CD06, macimorelin, The metabolism of Macimorelin can be decreased when combined with Amiodarone.]
[L02BB05, apalutamide, The metabolism of Apalutamide can be decreased when combined with Amiodarone.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Amiodarone.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Amiodarone.]
[H03BB01, carbimazole, The therapeutic efficacy of Carbimazole can be decreased when used in combination with Amiodarone.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Amiodarone.]
[C07AG02, carvedilol, The therapeutic efficacy of Carvedilol can be increased when used in combination with Amiodarone.]
[B02BX09, fostamatinib, The metabolism of Fostamatinib can be decreased when combined with Amiodarone.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Amiodarone.]
[B02BX08, avatrombopag, The metabolism of Amiodarone can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The metabolism of Baricitinib can be decreased when combined with Amiodarone.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Amiodarone.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Amiodarone.]
[C07AB08, celiprolol, The therapeutic efficacy of Celiprolol can be increased when used in combination with Amiodarone.]
[H01CC03, elagolix, The metabolism of Amiodarone can be decreased when combined with Elagolix.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Amiodarone.]
[N03AX17, stiripentol, The metabolism of Amiodarone can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Amiodarone.]
[J05AX24, tecovirimat, The metabolism of Amiodarone can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Amiodarone.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be decreased when combined with Amiodarone.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Amiodarone.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Amiodarone.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Amiodarone.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Amiodarone.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Amiodarone.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Amiodarone.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be increased when it is combined with Amiodarone.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Amiodarone.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Amiodarone.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be decreased when combined with Amiodarone.]
[R03BB08, revefenacin, The serum concentration of Revefenacin can be increased when it is combined with Amiodarone.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Amiodarone.]
[L04AA39, emapalumab, The metabolism of Amiodarone can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Carmustine can be decreased when combined with Amiodarone.]
[L01EX12, larotrectinib, The metabolism of Larotrectinib can be decreased when combined with Amiodarone.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Amiodarone.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Amiodarone.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Amiodarone.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Amiodarone.]
[C01BG07, cifenline, Amiodarone may increase the QTc-prolonging activities of Cibenzoline.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Amiodarone is combined with Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Amiodarone.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Ciprofibrate.]
[S01ED05, carteolol, The risk or severity of adverse effects can be increased when Amiodarone is combined with Carteolol.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Amiodarone.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Amiodarone.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Amiodarone is combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Amiodarone can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The serum concentration of Solriamfetol can be increased when it is combined with Amiodarone.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Amiodarone.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Amiodarone.]
[H02AB14, cloprednol, The metabolism of Cloprednol can be decreased when combined with Amiodarone.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Amiodarone.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Ubidecarenone.]
[V03AE07, calcium acetate, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium acetate.]
[C09CA06, candesartan, The metabolism of Amiodarone can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Amiodarone can be increased when combined with Etanercept.]
[A12CC06, magnesium lactate, The risk or severity of hypotension can be increased when Magnesium lactate is combined with Amiodarone.]
[V03AE02, sevelamer, The excretion of Amiodarone can be increased when combined with Sevelamer.]
[H02AB17, cortivazol, The metabolism of Cortivazol can be decreased when combined with Amiodarone.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Amiodarone.]
[L01FX14, polatuzumab vedotin, The risk or severity of adverse effects can be increased when Amiodarone is combined with Polatuzumab vedotin.]
[L01XX66, selinexor, The metabolism of Selinexor can be decreased when combined with Amiodarone.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Amiodarone.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Amiodarone.]
[C03BX03, cicletanine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Cicletanine.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Amiodarone.]
[L04AA44, upadacitinib, The metabolism of Upadacitinib can be decreased when combined with Amiodarone.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Amiodarone.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Amiodarone.]
[N07XX11, pitolisant, The serum concentration of Amiodarone can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The serum concentration of Pretomanid can be increased when it is combined with Amiodarone.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Amiodarone.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Amiodarone.]
[C03AA09, cyclothiazide, Amiodarone may increase the hypotensive activities of Cyclothiazide.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Amiodarone.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin pork.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Amiodarone.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Amiodarone.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Amiodarone.]
[J01DB09, cephradine, The metabolism of Amiodarone can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be increased when it is combined with Amiodarone.]
[G03DB05, demegestone, The metabolism of Demegestone can be decreased when combined with Amiodarone.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Amiodarone.]
[N02CC08, lasmiditan, Lasmiditan may increase the bradycardic activities of Amiodarone.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Amiodarone.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Amiodarone.]
[B06AX03, voxelotor, The serum concentration of Amiodarone can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Amiodarone can be decreased when it is combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Amiodarone.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Amiodarone.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Amiodarone.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Amiodarone.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Amiodarone.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Amiodarone.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Amiodarone.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be increased when it is combined with Amiodarone.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be decreased when combined with Amiodarone.]
[J05AB16, remdesivir, The metabolism of Remdesivir can be decreased when combined with Amiodarone.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Amiodarone.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be increased when it is combined with Amiodarone.]
[J05AE05, amprenavir, The serum concentration of Amiodarone can be increased when it is combined with Amprenavir.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Amiodarone.]
[L04AA38, ozanimod, The metabolism of Amiodarone can be decreased when combined with Ozanimod.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Amiodarone.]
[G03DB08, dienogest, The metabolism of Dienogest can be decreased when combined with Amiodarone.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Amiodarone.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Amiodarone.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be decreased when combined with Amiodarone.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Amiodarone.]
[C08CA16, clevidipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Clevidipine.]
[C01BD07, dronedarone, Amiodarone may increase the QTc-prolonging activities of Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Amiodarone can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Amiodarone can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Amiodarone.]
[C02AA06, methoserpidine, Amiodarone may increase the hypotensive activities of Methoserpidine.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be decreased when combined with Amiodarone.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Amiodarone.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be increased when it is combined with Amiodarone.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Opicapone.]
[D07XB03, fluprednidene, The metabolism of Fluprednidene can be decreased when combined with Amiodarone.]
[M01AC04, droxicam, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Droxicam.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be increased when it is combined with Amiodarone.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be increased when it is combined with Amiodarone.]
[M02AA27, dexketoprofen, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Amiodarone.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be increased when it is combined with Amiodarone.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Amiodarone.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Amiodarone.]
[J05AX29, fostemsavir, The metabolism of Fostemsavir can be decreased when combined with Amiodarone.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Amiodarone.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Amiodarone.]
[L04AC19, satralizumab, The serum concentration of Amiodarone can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Amiodarone.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Amiodarone.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Amiodarone.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Amiodarone.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Amiodarone.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Amiodarone.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Amiodarone.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Amiodarone.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Amiodarone.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Amiodarone.]
[A11CC05, cholecalciferol, The metabolism of Cholecalciferol can be decreased when combined with Amiodarone.]
[N02BA07, ethenzamide, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Ethenzamide.]
[C10AC01, cholestyramine resin, The serum concentration of Amiodarone can be decreased when it is combined with Cholestyramine.]
[N02BA03, choline salicylate, The serum concentration of Choline salicylate can be increased when it is combined with Amiodarone.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Vinpocetine.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be decreased when combined with Amiodarone.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Amiodarone.]
[M02AA06, etofenamate, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Etofenamate.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Etofibrate.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Amiodarone.]
[A16AX20, lonafarnib, The metabolism of Amiodarone can be decreased when combined with Lonafarnib.]
[M09AA01, hydroquinine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Hydroquinine.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Amiodarone.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be decreased when combined with Amiodarone.]
[P03AX07, abametapir, The serum concentration of Amiodarone can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Amiodarone is combined with Vericiguat.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Amiodarone.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Amiodarone.]
[N03AX10, felbamate, The metabolism of Felbamate can be decreased when combined with Amiodarone.]
[M01AE05, fenbufen, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Fenbufen.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be increased when it is combined with Amiodarone.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Fenoldopam is combined with Amiodarone.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Amiodarone.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Flumequine is combined with Amiodarone.]
[R03BA03, flunisolide, The metabolism of Flunisolide can be decreased when combined with Amiodarone.]
[S02BA08, fluocinolone acetonide, The metabolism of Fluocinolone acetonide can be decreased when combined with Amiodarone.]
[R03CC15, formoterol, The risk or severity of QTc prolongation can be increased when Formoterol is combined with Amiodarone.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Amiodarone.]
[L01EK03, tivozanib, The serum concentration of Tivozanib can be increased when it is combined with Amiodarone.]
[N01AB05, trichloroethylene, Amiodarone may increase the cardiodepressant activities of Trichloroethylene.]
[H04AA02, dasiglucagon, Amiodarone may increase the hypotensive activities of Dasiglucagon.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Amiodarone.]
[A02BA01, cimetidine, The serum concentration of Amiodarone can be increased when it is combined with Cimetidine.]
[N07CA02, cinnarizine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Cinnarizine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Amiodarone.]
[L01XX73, sotorasib, The serum concentration of Amiodarone can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Amiodarone.]
[S03AA07, ciprofloxacin, The metabolism of Amiodarone can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The serum concentration of Cisplatin can be increased when it is combined with Amiodarone.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Citalopram.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be increased when it is combined with Amiodarone.]
[C03DA05, finerenone, The serum concentration of the active metabolites of Finerenone can be increased when Finerenone is used in combination with Amiodarone.]
[L04AA48, belumosudil, The metabolism of Belumosudil can be decreased when combined with Amiodarone.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Amiodarone is combined with Fexinidazole.]
[L01XX74, belzutifan, The serum concentration of Amiodarone can be decreased when it is combined with Belzutifan.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Mobocertinib.]
[L01FX23, tisotumab vedotin, The metabolism of Tisotumab vedotin can be decreased when combined with Amiodarone.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Amiodarone.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Amiodarone.]
[L04AA59, avacopan, The metabolism of Avacopan can be decreased when combined with Amiodarone.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Clemastine is combined with Amiodarone.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Amiodarone.]
[A10BB12, glimepiride, The metabolism of Glimepiride can be decreased when combined with Amiodarone.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Amiodarone.]
[A12AA02, calcium glubionate, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium glubionate anhydrous.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Amiodarone.]
[N06AX25, St. John's wort extract, The serum concentration of Amiodarone can be decreased when it is combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Asciminib can be increased when it is combined with Amiodarone.]
[L02BG06, exemestane, The metabolism of Exemestane can be decreased when combined with Amiodarone.]
[J05AX10, maribavir, The metabolism of Maribavir can be decreased when combined with Amiodarone.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Amiodarone.]
[J04BA01, clofazimine, The metabolism of Amiodarone can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Clofibrate can be decreased when combined with Amiodarone.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be decreased when combined with Amiodarone.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Amiodarone.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be increased when it is combined with Amiodarone.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Amiodarone.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Amiodarone.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be decreased when combined with Amiodarone.]
[S01EA04, clonidine, Clonidine may increase the atrioventricular blocking (AV block) activities of Amiodarone.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Amiodarone.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Tirzepatide.]
[J02AC06, oteseconazole, The therapeutic efficacy of Oteseconazole can be increased when used in combination with Amiodarone.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Amiodarone.]
[H01CC04, linzagolix, The serum concentration of Amiodarone can be increased when it is combined with Linzagolix.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be decreased when combined with Amiodarone.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Amiodarone.]
[A04AA02, granisetron, The metabolism of Granisetron can be decreased when combined with Amiodarone.]
[J05AX31, lenacapavir, The metabolism of Amiodarone can be decreased when combined with Lenacapavir.]
[L01XX77, adagrasib, The serum concentration of Adagrasib can be increased when it is combined with Amiodarone.]
[N05AH02, clozapine, The serum concentration of Clozapine can be increased when it is combined with Amiodarone.]
[L01EN04, futibatinib, The metabolism of Futibatinib can be decreased when combined with Amiodarone.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Amiodarone can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of QTc prolongation can be increased when Cocaine is combined with Amiodarone.]
[M09AX11, palovarotene, The serum concentration of Palovarotene can be increased when it is combined with Amiodarone.]
[C02KB01, metyrosine, Amiodarone may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Amiodarone can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Proquazone.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Amiodarone.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Amiodarone.]
[C10AC02, colestipol, The excretion of Amiodarone can be increased when combined with Colestipol.]
[L04AA13, leflunomide, The metabolism of Leflunomide can be decreased when combined with Amiodarone.]
[C01BA13, hydroquinidine, Amiodarone may increase the QTc-prolonging activities of Hydroquinidine.]
[A02AD04, hydrotalcite, The risk or severity of hypotension can be increased when Hydrotalcite is combined with Amiodarone.]
[N01AB07, desflurane, Amiodarone may increase the cardiodepressant activities of Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Amiodarone is combined with Tropisetron.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Amiodarone.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Imidazole salicylate.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Amiodarone can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Amiodarone.]
[B01AC10, indobufen, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Indobufen.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Amiodarone.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Amiodarone.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Amiodarone.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Amiodarone.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Amiodarone.]
[J02AC02, itraconazole, The serum concentration of Amiodarone can be increased when it is combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Bemiparin.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Amiodarone.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Emedastine is combined with Amiodarone.]
[N05BA10, ketazolam, The metabolism of Ketazolam can be decreased when combined with Amiodarone.]
[M01AA06, kebuzone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Kebuzone.]
[L01EA01, imatinib, The serum concentration of Imatinib can be increased when it is combined with Amiodarone.]
[J02AC04, posaconazole, The metabolism of Amiodarone can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Amiodarone.]
[C08CA09, lacidipine, Amiodarone may increase the hypotensive activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Amiodarone.]
[N03AX09, lamotrigine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Lamotrigine.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Amiodarone.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Amiodarone.]
[S01BA03, cortisone, The metabolism of Cortisone can be decreased when combined with Amiodarone.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Amiodarone.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Amiodarone.]
[M01AB09, lonazolac, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Lonazolac.]
[R06AX13, loratadine, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Loratadine.]
[M02AA31, loxoprofen, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Loxoprofen.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Lisinopril is combined with Amiodarone.]
[A02AD02, magaldrate, The risk or severity of hypotension can be increased when Magaldrate is combined with Amiodarone.]
[A06AD01, magnesium carbonate, The risk or severity of hypotension can be increased when Magnesium carbonate is combined with Amiodarone.]
[C08CA11, manidipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Mebeverine.]
[C07AA14, mepindolol, The therapeutic efficacy of Mepindolol can be increased when used in combination with Amiodarone.]
[H02AB15, meprednisone, The metabolism of Meprednisone can be decreased when combined with Amiodarone.]
[R06AD07, mequitazine, The metabolism of Amiodarone can be decreased when combined with Mequitazine.]
[C01EB10, adenosine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Adenosine.]
[C04AX01, cyclandelate, The risk or severity of adverse effects can be increased when Amiodarone is combined with Cyclandelate.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Amiodarone.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Amiodarone.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Amiodarone is combined with Melperone.]
[C03AA07, cyclopenthiazide, Amiodarone may increase the hypotensive activities of Cyclopenthiazide.]
[J01FA03, midecamycin, The metabolism of Midecamycin can be decreased when combined with Amiodarone.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Miglitol.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Amiodarone.]
[L01AA01, cyclophosphamide, The risk or severity of pulmonary toxicity can be increased when Cyclophosphamide is combined with Amiodarone.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Amiodarone.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Amiodarone.]
[N06BA07, modafinil, The metabolism of Modafinil can be decreased when combined with Amiodarone.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Amiodarone.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Amiodarone.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be increased when combined with Amiodarone.]
[M02AA02, mofebutazone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Amiodarone can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Moxonidine.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Amiodarone.]
[J05AF10, entecavir, The metabolism of Entecavir can be decreased when combined with Amiodarone.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Amiodarone.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Amiodarone.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Amiodarone.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Amiodarone.]
[G03XA01, danazol, The metabolism of Amiodarone can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Amiodarone.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Amiodarone.]
[L01DB02, daunorubicin, The metabolism of Amiodarone can be decreased when combined with Daunorubicin.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Amiodarone.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Amiodarone.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Amiodarone.]
[B05XA15, potassium lactate, Potassium lactate may increase the hyperkalemic activities of Amiodarone.]
[C07AB12, nebivolol, The therapeutic efficacy of Nebivolol can be increased when used in combination with Amiodarone.]
[N06AX06, nefazodone, The metabolism of Amiodarone can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nicorandil.]
[L02BB02, nilutamide, The metabolism of Amiodarone can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be decreased when combined with Amiodarone.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be decreased when combined with Amiodarone.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be increased when it is combined with Amiodarone.]
[M03AC11, cisatracurium, Amiodarone may increase the neuromuscular blocking activities of Cisatracurium.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Amiodarone.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Amiodarone.]
[A07EC03, olsalazine, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Olsalazine.]
[N06AA01, desipramine, The metabolism of Amiodarone can be decreased when combined with Desipramine.]
[C01AA07, deslanoside, The serum concentration of Deslanoside can be increased when it is combined with Amiodarone.]
[C09XA02, aliskiren, The metabolism of Aliskiren can be decreased when combined with Amiodarone.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Amiodarone.]
[M01AE12, oxaprozin, The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Amiodarone.]
[N03AF02, oxcarbazepine, The metabolism of Amiodarone can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Dexamethasone can be decreased when combined with Amiodarone.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Amiodarone.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Amiodarone.]
[L04AB04, adalimumab, The metabolism of Amiodarone can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Amiodarone.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Amiodarone.]
[R05DA09, dextromethorphan, The serum concentration of Dextromethorphan can be increased when it is combined with Amiodarone.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Amiodarone.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Amiodarone.]
[B01AC04, clopidogrel, The risk or severity of bleeding can be increased when Amiodarone is combined with Clopidogrel.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be increased when it is combined with Amiodarone.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Amiodarone.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Diazoxide.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Diclofenamide.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Amiodarone.]
[J01CF01, dicloxacillin, The metabolism of Amiodarone can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Amiodarone.]
[C02DG01, pinacidil, The metabolism of Pinacidil can be decreased when combined with Amiodarone.]
[A03AX04, pinaverium, The risk or severity of adverse effects can be increased when Amiodarone is combined with Pinaverium.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be decreased when combined with Amiodarone.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Pipamperone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Amiodarone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Amiodarone.]
[A16AB04, agalsidase beta, The therapeutic efficacy of Agalsidase beta can be decreased when used in combination with Amiodarone.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be decreased when combined with Amiodarone.]
[C08CA03, isradipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Difluocortolone can be decreased when combined with Amiodarone.]
[N02BA11, diflunisal, The risk or severity of hyperkalemia can be increased when Diflunisal is combined with Amiodarone.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Amiodarone.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Amiodarone.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be decreased when combined with Amiodarone.]
[C04AE04, dihydroergocristine, The serum concentration of Dihydroergocristine can be increased when it is combined with Amiodarone.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Amiodarone.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Amiodarone.]
[J05AE08, atazanavir, The serum concentration of Amiodarone can be increased when it is combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Amiodarone can be decreased when combined with Treprostinil.]
[H03BC01, potassium perchlorate, The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Amiodarone.]
[C08DB01, diltiazem, The risk or severity of adverse effects can be increased when Amiodarone is combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Amiodarone.]
[M02AX03, dimethyl sulfoxide, The metabolism of Amiodarone can be decreased when combined with Dimethyl sulfoxide.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be increased when it is combined with Amiodarone.]
[N02BB04, propyphenazone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Proglumetacin.]
[C05CA03, diosmin, The metabolism of Amiodarone can be decreased when combined with Diosmin.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be increased when it is combined with Amiodarone.]
[R06AA02, diphenhydramine, The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Amiodarone.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Amiodarone.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Quinapril is combined with Amiodarone.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Dipyridamole is combined with Amiodarone.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Amiodarone.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Amiodarone.]
[S01XA23, sirolimus, Amiodarone may increase the immunosuppressive activities of Sirolimus.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Amiodarone.]
[C01BA03, disopyramide, Amiodarone may increase the QTc-prolonging activities of Disopyramide.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Amiodarone.]
[S02AA12, rifamycin SV, The metabolism of Amiodarone can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Rifapentine can be decreased when combined with Amiodarone.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Amiodarone.]
[N07XX02, riluzole, The metabolism of Riluzole can be decreased when combined with Amiodarone.]
[N05AX08, risperidone, Amiodarone may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, The metabolism of Levocetirizine can be decreased when combined with Amiodarone.]
[N01BB09, ropivacaine, The metabolism of Ropivacaine can be decreased when combined with Amiodarone.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Amiodarone.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Amiodarone.]
[A04AD12, aprepitant, The metabolism of Aprepitant can be decreased when combined with Amiodarone.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Amiodarone.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Amiodarone.]
[J05AE07, fosamprenavir, The serum concentration of Amiodarone can be increased when it is combined with Fosamprenavir.]
[G04BE08, tadalafil, The serum concentration of Tadalafil can be increased when it is combined with Amiodarone.]
[S01BC05, ketorolac, The metabolism of Amiodarone can be decreased when combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Amiodarone.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be decreased when combined with Amiodarone.]
[N02BA06, salsalate, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Salsalate.]
[R03AC12, salmeterol, The metabolism of Salmeterol can be decreased when combined with Amiodarone.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Amiodarone.]
[C01CA04, dopamine, The serum concentration of Dopamine can be increased when it is combined with Amiodarone.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Amiodarone.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Amiodarone.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Amiodarone.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Amiodarone.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Amiodarone.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Amiodarone.]
[N01AB08, sevoflurane, Amiodarone may increase the cardiodepressant activities of Sevoflurane.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Amiodarone.]
[A08AA10, sibutramine, The metabolism of Sibutramine can be decreased when combined with Amiodarone.]
[C10AA01, simvastatin, The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.]
[V03AG05, sodium phosphate, Sodium phosphate, monobasic may increase the hyperkalemic activities of Amiodarone.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Amiodarone.]
[C09AA11, spirapril, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Spirapril.]
[G03DB01, dydrogesterone, The metabolism of Dydrogesterone can be decreased when combined with Amiodarone.]
[R03DA01, dyphylline, The serum concentration of Dyphylline can be increased when it is combined with Amiodarone.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Sultopride is combined with Amiodarone.]
[C07AB13, talinolol, The therapeutic efficacy of Talinolol can be increased when used in combination with Amiodarone.]
[H01AA01, corticotropin, The metabolism of Corticotropin can be decreased when combined with Amiodarone.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Temafloxacin.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Amiodarone.]
[G04CA03, terazosin, The risk or severity of hypotension can be increased when Terazosin is combined with Amiodarone.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Amiodarone.]
[G04BD05, terodiline, The risk or severity of adverse effects can be increased when Amiodarone is combined with Terodiline.]
[C07AA16, tertatolol, The therapeutic efficacy of Tertatolol can be increased when used in combination with Amiodarone.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Amiodarone resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Emetine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Amiodarone.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Amiodarone.]
[M01AG02, tolfenamic acid, The metabolism of Tolfenamic acid can be decreased when combined with Amiodarone.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Amiodarone.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Amiodarone.]
[N03AX11, topiramate, The metabolism of Amiodarone can be increased when combined with Topiramate.]
[L02BA02, toremifene, The metabolism of Toremifene can be decreased when combined with Amiodarone.]
[C03CA04, torsemide, The metabolism of Amiodarone can be decreased when combined with Torasemide.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Trandolapril is combined with Amiodarone.]
[H02CA01, trilostane, The metabolism of Trilostane can be decreased when combined with Amiodarone.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Amiodarone.]
[N01AB04, enflurane, Amiodarone may increase the cardiodepressant activities of Enflurane.]
[C02CA06, urapidil, The risk or severity of hypotension can be increased when Urapidil is combined with Amiodarone.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Amiodarone.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Amiodarone.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Amiodarone.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be decreased when combined with Amiodarone.]
[S01GA03, xylometazoline, The risk or severity of adverse effects can be increased when Amiodarone is combined with Xylometazoline.]
[C08CA12, mepirodipine, The metabolism of Barnidipine can be decreased when combined with Amiodarone.]
[S01EA01, epinephrine, The metabolism of Amiodarone can be decreased when combined with Epinephrine.]
[C09AA15, zofenopril, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Zofenopril.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Amiodarone.]
[M01AB04, zomepirac, The metabolism of Zomepirac can be decreased when combined with Amiodarone.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Zonisamide.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Amiodarone.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Amiodarone.]
[C02AC02, guanfacine, The metabolism of Guanfacine can be decreased when combined with Amiodarone.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Iloprost is combined with Amiodarone.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Moricizine.]
[G02AB03, ergonovine, The serum concentration of Ergometrine can be increased when it is combined with Amiodarone.]
[C04AE01, ergoloid mesylates, USP, The serum concentration of Ergoloid mesylate can be increased when it is combined with Amiodarone.]
[N02CA02, ergotamine, The metabolism of Amiodarone can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, The metabolism of Amiodarone can be decreased when combined with Valproic acid.]
[C01DA13, erythrityl tetranitrate, Amiodarone may increase the vasodilatory activities of Erythrityl tetranitrate.]
[S01AA17, erythromycin, The metabolism of Erythromycin can be decreased when combined with Amiodarone.]
[N05CD04, estazolam, The metabolism of Estazolam can be decreased when combined with Amiodarone.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be decreased when combined with Amiodarone.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Amiodarone.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Amiodarone.]
[L01XX11, estramustine, The metabolism of Estramustine can be decreased when combined with Amiodarone.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Amiodarone.]
[J04AK02, ethambutol, The metabolism of Amiodarone can be decreased when combined with Ethambutol.]
[R03BA05, fluticasone, The metabolism of Amiodarone can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be increased when combined with Amiodarone.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Amiodarone.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Amifostine.]
[C01BD05, ibutilide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Ibutilide.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Ethosuximide.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Amiodarone.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Amiodarone.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Amiodarone.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Amiodarone.]
[C01BA05, ajmaline, Amiodarone may increase the QTc-prolonging activities of Ajmaline.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Amiodarone.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Amiodarone.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Amiodarone.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Amiodarone.]
[R06AX12, terfenadine, The metabolism of Amiodarone can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Amiodarone.]
[N06AB08, fluvoxamine, The metabolism of Fluvoxamine can be decreased when combined with Amiodarone.]
[C01BB03, tocainide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Tocainide.]
[C01BC08, encainide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Encainide.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Amiodarone.]
[C10AA03, pravastatin, The metabolism of Pravastatin can be increased when combined with Amiodarone.]
[A05AA01, chenodeoxycholic acid, The metabolism of Chenodeoxycholic acid can be decreased when combined with Amiodarone.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Amiodarone.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Amiodarone.]
[C08CA02, felodipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of adverse effects can be increased when Amiodarone is combined with Fendiline.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Amiodarone.]
[M01AE04, fenoprofen, The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Amiodarone.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Amiodarone is combined with Fentanyl.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Amiodarone.]
[L01BB06, clofarabine, The serum concentration of Clofarabine can be increased when it is combined with Amiodarone.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Amiodarone.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Amiodarone.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Amiodarone.]
[N02BG04, floctafenine, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Floctafenine.]
[J01CF05, floxacillin, The metabolism of Amiodarone can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Amiodarone can be decreased when combined with Fluconazole.]
[H02AA02, fludrocortisone, The metabolism of Fludrocortisone can be decreased when combined with Amiodarone.]
[D07XB01, flumethasone, The metabolism of Flumethasone can be decreased when combined with Amiodarone.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Amiodarone.]
[D07AC08, fluocinonide, The metabolism of Fluocinonide can be decreased when combined with Amiodarone.]
[H02AB03, fluocortolone, The metabolism of Fluocortolone can be decreased when combined with Amiodarone.]
[V03AZ01, ethanol, Ethanol may increase the hypotensive activities of Amiodarone.]
[L01BC02, fluorouracil, The metabolism of Amiodarone can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Amiodarone.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Flupentixol.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Amiodarone.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Amiodarone.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Amiodarone is combined with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Amiodarone.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Amiodarone.]
[M03AA01, alcuronium, Amiodarone may increase the neuromuscular blocking activities of Alcuronium.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Amiodarone.]
[J05AE10, darunavir, The serum concentration of Amiodarone can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Furosemide is combined with Amiodarone.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Amiodarone.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be increased when it is combined with Amiodarone.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Amiodarone.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Amiodarone.]
[M03AC02, gallamine, Amiodarone may increase the neuromuscular blocking activities of Gallamine.]
[C08DA02, gallopamil, The risk or severity of adverse effects can be increased when Amiodarone is combined with Gallopamil.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Amiodarone.]
[N03AA04, barbexaclone, The metabolism of Amiodarone can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The metabolism of Gemfibrozil can be decreased when combined with Amiodarone.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Amiodarone.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Amiodarone.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Amiodarone.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Amiodarone.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be increased when it is combined with Amiodarone.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Liraglutide.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Amiodarone.]
[A12AA10, calcium gluceptate, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium glucoheptonate.]
[A12AA30, calcium levulinate, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium levulinate.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Methsuximide.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be decreased when combined with Amiodarone.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Amiodarone.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Amiodarone.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Amiodarone.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Amiodarone.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Amiodarone.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Amiodarone.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Amiodarone.]
[C05AE01, nitroglycerin, Amiodarone may increase the vasodilatory activities of Nitroglycerin.]
[C01BD04, dofetilide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Dofetilide.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Amiodarone.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Amiodarone.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Amiodarone.]
[C07AB09, esmolol, The therapeutic efficacy of Esmolol can be increased when used in combination with Amiodarone.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Amiodarone.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Amiodarone.]
[D01BA01, griseofulvin, The metabolism of Amiodarone can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Amiodarone may increase the hypotensive activities of Guanethidine.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amiodarone.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Amiodarone.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Haloperidol.]
[N01AB01, halothane, Amiodarone may increase the cardiodepressant activities of Halothane.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Amiodarone.]
[N05AH04, quetiapine, The serum concentration of Quetiapine can be increased when it is combined with Amiodarone.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin aspart.]
[L01CE02, irinotecan, The serum concentration of SN-38, an active metabolite of Irinotecan, can be increased when used in combination with Amiodarone.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Amiodarone is combined with Losartan.]
[S01XA14, heparin, The risk or severity of hyperkalemia can be increased when Heparin is combined with Amiodarone.]
[B05CB03, magnesium citrate, The risk or severity of hypotension can be increased when Magnesium citrate is combined with Amiodarone.]
[A12CC03, magnesium gluconate, The risk or severity of hypotension can be increased when Magnesium gluconate is combined with Amiodarone.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Amiodarone.]
[A07EC02, mesalamine, The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Amiodarone.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Amiodarone.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Amiodarone.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Amiodarone.]
[C08CA10, nilvadipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nimesulide.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Amiodarone.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Perindopril is combined with Amiodarone.]
[C02DB02, hydralazine, The metabolism of Amiodarone can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Amiodarone.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Amiodarone.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Amiodarone.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Amiodarone.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Amiodarone.]
[B05XA17, potassium acetate, Potassium acetate may increase the hyperkalemic activities of Amiodarone.]
[S01XA07, aluminum potassium sulfate, Potassium alum may increase the hyperkalemic activities of Amiodarone.]
[A12BA02, potassium citrate, Potassium citrate may increase the hyperkalemic activities of Amiodarone.]
[G04BD06, propiverine, The metabolism of Propiverine can be decreased when combined with Amiodarone.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Amiodarone.]
[G03DA03, 17-alpha-hydroxyprogesterone, The metabolism of Hydroxyprogesterone can be decreased when combined with Amiodarone.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Rifabutin can be decreased when combined with Amiodarone.]
[C02AC06, rilmenidine, Amiodarone may increase the hypotensive activities of Rilmenidine.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Amiodarone.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Amiodarone.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Amiodarone.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Amiodarone.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Amiodarone.]
[N01AH03, sufentanil, The metabolism of Sufentanil can be decreased when combined with Amiodarone.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Amiodarone.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Amiodarone.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Amiodarone.]
[M03BX02, tizanidine, The serum concentration of Tizanidine can be increased when it is combined with Amiodarone.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Amiodarone.]
[C03BA11, indapamide, The metabolism of Indapamide can be decreased when combined with Amiodarone.]
[S01BC01, indomethacin, The metabolism of Indomethacin can be decreased when combined with Amiodarone.]
[C02CA02, indoramin, The risk or severity of hypotension can be increased when Indoramin is combined with Amiodarone.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be decreased when combined with Amiodarone.]
[S01XA28, varenicline, The excretion of Varenicline can be decreased when combined with Amiodarone.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Amiodarone.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Amiodarone.]
[N05CH02, ramelteon, The serum concentration of Ramelteon can be increased when it is combined with Amiodarone.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Amiodarone.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be increased when combined with Amiodarone.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Amiodarone.]
[C07AA01, alprenolol, The therapeutic efficacy of Alprenolol can be increased when used in combination with Amiodarone.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Amiodarone.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Amiodarone.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Amiodarone.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be decreased when combined with Amiodarone.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Amiodarone.]
[P01AX06, atovaquone, The metabolism of Atovaquone can be decreased when combined with Amiodarone.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Amiodarone is combined with Imidapril.]
[N01AB06, isoflurane, Amiodarone may increase the cardiodepressant activities of Isoflurane.]
[J04AC01, isoniazid, The metabolism of Amiodarone can be decreased when combined with Isoniazid.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Exenatide.]
[C01DA14, isosorbide mononitrate, Amiodarone may increase the vasodilatory activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Amiodarone may increase the vasodilatory activities of Isosorbide dinitrate.]
[D10BA01, isotretinoin, The metabolism of Isotretinoin can be decreased when combined with Amiodarone.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Isoxsuprine.]
[P02CF01, ivermectin, The metabolism of Ivermectin can be decreased when combined with Amiodarone.]
[N06AX18, reboxetine, The metabolism of Reboxetine can be decreased when combined with Amiodarone.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amiodarone.]
[L04AC07, tocilizumab, The metabolism of Amiodarone can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Amiodarone.]
[C02KD01, ketanserin, Amiodarone may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Amiodarone.]
[J02AB02, ketoconazole, The metabolism of Amiodarone can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Amiodarone can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be decreased when combined with Amiodarone.]
[M02AA10, ketoprofen, The metabolism of Amiodarone can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Amiodarone can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Amiodarone can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Amiodarone.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Amiodarone.]
[M01AE11, tiaprofenic acid, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The therapeutic efficacy of Labetalol can be increased when used in combination with Amiodarone.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Amiodarone.]
[J05AX09, maraviroc, The metabolism of Maraviroc can be decreased when combined with Amiodarone.]
[C02AA05, deserpidine, Amiodarone may increase the hypotensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Amiodarone.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Amiodarone.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Amiodarone.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Amiodarone.]
[R05CB06, ambroxol, The metabolism of Ambroxol can be decreased when combined with Amiodarone.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be decreased when combined with Amiodarone.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Amiodarone is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of generalized seizure and bradycardia can be increased when Amiodarone is combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Lidoflazine.]
[N06BA13, armodafinil, The metabolism of Amiodarone can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Amiodarone.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Amiodarone.]
[N02CA07, lisuride, The serum concentration of Lisuride can be increased when it is combined with Amiodarone.]
[A07DA03, loperamide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Loperamide.]
[A12AA11, calcium pangamate, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium pangamate.]
[N05BA06, lorazepam, The metabolism of Lorazepam can be decreased when combined with Amiodarone.]
[C10AA02, lovastatin, The serum concentration of Lovastatin can be increased when it is combined with Amiodarone.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Amiodarone.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Amiodarone.]
[B05XA11, magnesium chloride, The risk or severity of hypotension can be increased when Magnesium chloride is combined with Amiodarone.]
[G04BX01, magnesium hydroxide, The risk or severity of hypotension can be increased when Magnesium hydroxide is combined with Amiodarone.]
[A12CC10, magnesium oxide, The risk or severity of hypotension can be increased when Magnesium oxide is combined with Amiodarone.]
[V04CC02, magnesium sulfate, The risk or severity of adverse effects can be increased when Amiodarone is combined with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Amiodarone.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Amiodarone.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Amiodarone.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Amiodarone.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Amiodarone.]
[M02AA18, meclofenamic acid, The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Amiodarone.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Amiodarone.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Amiodarone.]
[G03DB03, medrogestone, The metabolism of Medrogestone can be decreased when combined with Amiodarone.]
[P01BC02, mefloquine, The metabolism of Mefloquine can be decreased when combined with Amiodarone.]
[B01AB06, nadroparin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Dalteparin.]
[N05CH01, melatonin, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Melatonin.]
[N06DX01, memantine, The serum concentration of Memantine can be increased when it is combined with Amiodarone.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Amiodarone.]
[N03AB04, mephenytoin, The metabolism of Amiodarone can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Amiodarone can be increased when combined with Methylphenobarbital.]
[L02BG01, aminoglutethimide, The metabolism of Amiodarone can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Amiodarone.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Amiodarone.]
[A10BA02, metformin, The serum concentration of Metformin can be increased when it is combined with Amiodarone.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Amiodarone.]
[H01CB03, lanreotide, The metabolism of Amiodarone can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Amiodarone.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Amiodarone.]
[N05CM01, methaqualone, The metabolism of Methaqualone can be decreased when combined with Amiodarone.]
[J05AF05, lamivudine, The serum concentration of Lamivudine can be increased when it is combined with Amiodarone.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Amiodarone.]
[G02CB05, metergoline, The serum concentration of Metergoline can be increased when it is combined with Amiodarone.]
[H03BB02, methimazole, The therapeutic efficacy of Methimazole can be decreased when used in combination with Amiodarone.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be decreased when combined with Amiodarone.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Amiodarone.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Amiodarone is combined with Ziconotide.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Amiodarone.]
[N05AA02, methotrimeprazine, The risk or severity of hypotension can be increased when Methotrimeprazine is combined with Amiodarone.]
[N02BG09, methoxyflurane, Amiodarone may increase the cardiodepressant activities of Methoxyflurane.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Amiodarone.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Amiodarone.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Amiodarone.]
[V04CG05, methylene blue, The metabolism of Amiodarone can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The serum concentration of Methylergometrine can be increased when it is combined with Amiodarone.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Amiodarone.]
[H02AB04, methylprednisolone, The metabolism of Methylprednisolone can be decreased when combined with Amiodarone.]
[N03AF03, rufinamide, The metabolism of Amiodarone can be increased when combined with Rufinamide.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Amiodarone.]
[N02CA04, methysergide, The serum concentration of Methysergide can be increased when it is combined with Amiodarone.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Amiodarone.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Amiodarone.]
[C07AB02, metoprolol, The therapeutic efficacy of Metoprolol can be increased when used in combination with Amiodarone.]
[P01AB01, metronidazole, The metabolism of Amiodarone can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Amiodarone can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Amiodarone.]
[S02AA13, miconazole, The metabolism of Amiodarone can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Amiodarone.]
[B01AB07, parnaparin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Parnaparin.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Amiodarone.]
[C01CA17, midodrine, Midodrine may increase the bradycardic activities of Amiodarone.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be decreased when combined with Amiodarone.]
[B01AB10, tinzaparin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Tinzaparin.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Amiodarone.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Amiodarone.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Amiodarone.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Amiodarone.]
[J01FA11, miocamycin, The metabolism of Amiodarone can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Amiodarone can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Amiodarone.]
[L03AC01, aldesleukin, The metabolism of Amiodarone can be decreased when combined with Aldesleukin.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Amiodarone.]
[C01DA05, pentaerythritol tetranitrate, Amiodarone may increase the vasodilatory activities of Pentaerythritol tetranitrate.]
[R03BA09, fluticasone furoate, The metabolism of Fluticasone furoate can be decreased when combined with Amiodarone.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Amiodarone.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Amiodarone.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Amiodarone.]
[L04AB05, certolizumab pegol, The metabolism of Amiodarone can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Amiodarone can be decreased when combined with Eltrombopag.]
[G04BA01, ammonium chloride, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Ammonium chloride.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Amiodarone.]
[M03AC03, vecuronium, Amiodarone may increase the neuromuscular blocking activities of Vecuronium.]
[N05CA02, amobarbital, The metabolism of Amiodarone can be increased when combined with Amobarbital.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Raltegravir.]
[P01BA06, amodiaquine, The metabolism of Amiodarone can be decreased when combined with Amodiaquine.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Amiodarone.]
[G03XC01, raloxifene, The metabolism of Amiodarone can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Amiodarone.]
[N03AB05, fosphenytoin, The serum concentration of Amiodarone can be decreased when it is combined with Fosphenytoin.]
[C07AA12, nadolol, The therapeutic efficacy of Nadolol can be increased when used in combination with Amiodarone.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Amiodarone is combined with Ropinirole.]
[J01CF06, nafcillin, The therapeutic efficacy of Amiodarone can be decreased when used in combination with Nafcillin.]
[V03AB15, naloxone, The metabolism of Amiodarone can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Amiodarone.]
[L04AC03, anakinra, The metabolism of Amiodarone can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Amiodarone.]
[M02AA12, naproxen, The metabolism of Amiodarone can be decreased when combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Amiodarone can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Amiodarone.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Amiodarone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Amiodarone.]
[L02BG04, letrozole, The metabolism of Letrozole can be decreased when combined with Amiodarone.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Amiodarone.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Amiodarone.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Amiodarone is combined with Levosimendan.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Amiodarone.]
[J02AA01, amphotericin B, Amiodarone may decrease the nephrotoxic activities of Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Desvenlafaxine can be decreased when combined with Amiodarone.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Telmisartan is combined with Amiodarone.]
[H05BX02, paricalcitol, The metabolism of Paricalcitol can be decreased when combined with Amiodarone.]
[C10AD02, niacin, The metabolism of Amiodarone can be decreased when combined with Niacin.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Amiodarone.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nicardipine.]
[C04AE02, nicergoline, The serum concentration of Nicergoline can be increased when it is combined with Amiodarone.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Amiodarone.]
[N07BA01, nicotine, The metabolism of Nicotine can be decreased when combined with Amiodarone.]
[C08CA05, nifedipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Niflumic acid.]
[V03AB22, amyl nitrite, Amiodarone may increase the vasodilatory activities of Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nimodipine.]
[C08CA07, nisoldipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nisoldipine.]
[N05CD02, nitrazepam, The metabolism of Nitrazepam can be decreased when combined with Amiodarone.]
[C08CA08, nitrendipine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Amiodarone.]
[J01XE01, nitrofurantoin, The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Amiodarone.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Amiodarone.]
[N04BC05, pramipexole, The serum concentration of Pramipexole can be increased when it is combined with Amiodarone.]
[C02DD01, nitroprusside, Amiodarone may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, Amiodarone may increase the cardiodepressant activities of Nitrous oxide.]
[C01CA03, norepinephrine, The serum concentration of Norepinephrine can be increased when it is combined with Amiodarone.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Amiodarone.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Amiodarone.]
[C02KX01, bosentan, The metabolism of Bosentan can be decreased when combined with Amiodarone.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Amiodarone.]
[R05DA07, noscapine, The metabolism of Amiodarone can be decreased when combined with Noscapine.]
[G02CA02, nylidrin, The risk or severity of adverse effects can be increased when Amiodarone is combined with Nylidrin.]
[B01AB08, reviparin, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Reviparin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Amiodarone.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Amiodarone.]
[J01FA05, oleandomycin, The metabolism of Amiodarone can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Amiodarone can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Amiodarone.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Amiodarone.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Amiodarone.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Amiodarone.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Amiodarone.]
[C07AA02, oxprenolol, The therapeutic efficacy of Oxprenolol can be increased when used in combination with Amiodarone.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Amiodarone.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Amiodarone.]
[S01BC02, oxyphenbutazone, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Oxyphenbutazone.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amiodarone.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Amiodarone.]
[B01AB09, danaparoid, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Danaparoid.]
[M03AC01, pancuronium, Amiodarone may increase the neuromuscular blocking activities of Pancuronium.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be decreased when combined with Amiodarone.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Papaverine is combined with Amiodarone.]
[H02AB05, paramethasone, The metabolism of Paramethasone can be decreased when combined with Amiodarone.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Amiodarone.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Amiodarone.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Amiodarone.]
[C07AA23, penbutolol, The therapeutic efficacy of Penbutolol can be increased when used in combination with Amiodarone.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Amiodarone is combined with Penfluridol.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Amiodarone.]
[N05CA01, pentobarbital, The metabolism of Amiodarone can be increased when combined with Pentobarbital.]
[C04AD03, pentoxifylline, The serum concentration of Pentoxifylline can be increased when it is combined with Amiodarone.]
[N04BC02, pergolide, The serum concentration of Pergolide can be increased when it is combined with Amiodarone.]
[C08EX02, perhexiline, The risk or severity of adverse effects can be increased when Amiodarone is combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Amiodarone.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Amiodarone.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Amiodarone.]
[A10BA01, phenformin, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Phenformin.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Amiodarone.]
[N03AA02, phenobarbital, The metabolism of Amiodarone can be increased when combined with Phenobarbital.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Amiodarone.]
[C04AX02, phenoxybenzamine, The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Amiodarone.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Amiodarone.]
[A08AA01, phentermine, The metabolism of Phentermine can be decreased when combined with Amiodarone.]
[V03AB36, phentolamine, The risk or severity of hypotension can be increased when Phentolamine is combined with Amiodarone.]
[M02AA01, phenylbutazone, The metabolism of Amiodarone can be increased when combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Amiodarone is combined with Phenylephrine.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Amiodarone.]
[N03AB02, phenytoin, The serum concentration of Amiodarone can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Amiodarone can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Amiodarone.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Amiodarone.]
[C08CX01, mibefradil, The risk or severity of adverse effects can be increased when Amiodarone is combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Amiodarone.]
[C07AA03, pindolol, The therapeutic efficacy of Pindolol can be increased when used in combination with Amiodarone.]
[C10AA05, atorvastatin, The serum concentration of Atorvastatin can be increased when it is combined with Amiodarone.]
[J05AE01, saquinavir, The serum concentration of Amiodarone can be increased when it is combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Amiodarone.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Amiodarone.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Amiodarone.]
[S01BC06, piroxicam, The metabolism of Amiodarone can be decreased when combined with Piroxicam.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be decreased when combined with Amiodarone.]
[N02CX01, pizotyline, The risk or severity of hypotension can be increased when Pizotifen is combined with Amiodarone.]
[J05AG02, delavirdine, The metabolism of Amiodarone can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Amiodarone can be decreased when combined with Irbesartan.]
[D05AX05, tazarotene, The metabolism of Amiodarone can be decreased when combined with Tazarotene.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Amiodarone.]
[L02BG03, anastrozole, The metabolism of Amiodarone can be decreased when combined with Anastrozole.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Amiodarone.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Amiodarone.]
[L04AC08, canakinumab, The metabolism of Amiodarone can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Amiodarone may increase the hypotensive activities of Polythiazide.]
[J05AE03, ritonavir, The metabolism of Amiodarone can be decreased when combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Amiodarone.]
[B05XA01, potassium chloride, Potassium chloride may increase the hyperkalemic activities of Amiodarone.]
[V03AB21, potassium iodide, The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Amiodarone.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin lispro.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be increased when combined with Amiodarone.]
[C07AB01, practolol, The therapeutic efficacy of Practolol can be increased when used in combination with Amiodarone.]
[C01BA08, prajmaline, Amiodarone may increase the QTc-prolonging activities of Prajmaline.]
[N05BA11, prazepam, The metabolism of Prazepam can be decreased when combined with Amiodarone.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Amiodarone.]
[C02CA01, prazosin, The risk or severity of hypotension can be increased when Prazosin is combined with Amiodarone.]
[S03BA02, prednisolone, The metabolism of Prednisolone can be decreased when combined with Amiodarone.]
[H02AB07, prednisone, The metabolism of Prednisone can be decreased when combined with Amiodarone.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Antazoline is combined with Amiodarone.]
[C01DX02, prenylamine, The risk or severity of adverse effects can be increased when Amiodarone is combined with Prenylamine.]
[P01BA03, primaquine, The metabolism of Primaquine can be decreased when combined with Amiodarone.]
[N03AA03, primidone, The metabolism of Amiodarone can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Amiodarone can be increased when combined with Probenecid.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Probucol is combined with Amiodarone.]
[C01BA02, procainamide, The serum concentration of Procainamide can be increased when it is combined with Amiodarone.]
[S01HA05, procaine, Procaine may increase the orthostatic hypotensive activities of Amiodarone.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Amiodarone.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Amiodarone.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Amiodarone.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Amiodarone.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Amiodarone.]
[G03DB07, promegestone, The metabolism of Promegestone can be decreased when combined with Amiodarone.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Promethazine is combined with Amiodarone.]
[C01BC03, propafenone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Propafenone.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Amiodarone.]
[N05AC01, periciazine, The risk or severity of hypotension can be increased when Periciazine is combined with Amiodarone.]
[N05CM06, propiomazine, The risk or severity of hypotension can be increased when Propiomazine is combined with Amiodarone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Amiodarone.]
[N01AX10, propofol, The metabolism of Amiodarone can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be decreased when combined with Amiodarone.]
[C07AA05, propranolol, The therapeutic efficacy of Propranolol can be increased when used in combination with Amiodarone.]
[H03BA02, propylthiouracil, The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Amiodarone.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Amiodarone.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Amiodarone is combined with Epoprostenol.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Amiodarone.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Amiodarone.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Amiodarone.]
[N07XX07, dalfampridine, The serum concentration of Dalfampridine can be increased when it is combined with Amiodarone.]
[A12BA05, potassium gluconate, Potassium gluconate may increase the hyperkalemic activities of Amiodarone.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Amiodarone.]
[P01BD01, pyrimethamine, The metabolism of Amiodarone can be decreased when combined with Pyrimethamine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Amiodarone.]
[C01BA01, quinidine, The serum concentration of Quinidine can be increased when it is combined with Amiodarone.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Amiodarone.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Amiodarone.]
[C02AA01, rescinnamine, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Rescinnamine.]
[C02AA02, reserpine, The serum concentration of Reserpine can be increased when it is combined with Amiodarone.]
[J04AB02, rifampin, The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Roxithromycin can be decreased when combined with Amiodarone.]
[N02BA05, salicylamide, The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Amiodarone.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Amiodarone.]
[S01FA02, scopolamine, The metabolism of Scopolamine can be decreased when combined with Amiodarone.]
[N05CA06, secobarbital, The metabolism of Amiodarone can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Amiodarone.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Amiodarone is combined with Obinutuzumab.]
[V10XA01, sodium iodide I131, Amiodarone may decrease effectiveness of Iodide I-131 as a diagnostic agent.]
[H01CB01, somatostatin, The metabolism of Amiodarone can be decreased when combined with Somatostatin.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Amiodarone.]
[C07AA07, sotalol, The therapeutic efficacy of Sotalol can be increased when used in combination with Amiodarone.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Amiodarone.]
[C03DA01, spironolactone, The metabolism of Amiodarone can be decreased when combined with Spironolactone.]
[N05AL01, sulpiride, QT prolonging agents - QT prolonging agents]
[N05AC02, thioridazine, QT prolonging agents - QT prolonging agents]
[L01EX04, vandetanib, QT prolonging agents - QT prolonging agents]
[N06DA02, donepezil, QT prolonging agents - QT prolonging agents]
[S01AE07, moxifloxacin, QT prolonging agents - QT prolonging agents]
[C08EA02, bepridil, QT prolonging agents - QT prolonging agents]
[L01XX27, arsenic trioxide, QT prolonging agents - QT prolonging agents]
[J01MA09, sparfloxacin, QT prolonging agents - QT prolonging agents]
[S01AA26, azithromycin, QT prolonging agents - QT prolonging agents]
[B01AC23, cilostazol, QT prolonging agents - QT prolonging agents]
[J01FA09, clarithromycin, QT prolonging agents - QT prolonging agents]
[S01AE06, gatifloxacin, QT prolonging agents - QT prolonging agents]
[C01BD07, dronedarone, QT prolonging agents - QT prolonging agents]
[L01DB04, aclarubicin, QT prolonging agents - QT prolonging agents]
[P01BA01, chloroquine, QT prolonging agents - QT prolonging agents]
[N05AA01, chlorpromazine, QT prolonging agents - QT prolonging agents]
[N05AF03, chlorprothixene, QT prolonging agents - QT prolonging agents]
[S03AA07, ciprofloxacin, QT prolonging agents - QT prolonging agents]
[N06AB04, citalopram, QT prolonging agents - QT prolonging agents]
[L01EB10, mobocertinib, QT prolonging agents - QT prolonging agents]
[A04AA01, ondansetron, QT prolonging agents - QT prolonging agents]
[S02DA02, cocaine, QT prolonging agents - QT prolonging agents]
[C01BA13, hydroquinidine, QT prolonging agents - QT prolonging agents]
[P01CB01, meglumine antimoniate, QT prolonging agents - QT prolonging agents]
[L01XA03, oxaliplatin, QT prolonging agents - QT prolonging agents]
[A03FA02, cisapride, QT prolonging agents - QT prolonging agents]
[C01BA03, disopyramide, QT prolonging agents - QT prolonging agents]
[A03FA03, domperidone, QT prolonging agents - QT prolonging agents]
[N01AB08, sevoflurane, QT prolonging agents - QT prolonging agents]
[N05AD08, droperidol, QT prolonging agents - QT prolonging agents]
[C10AA01, simvastatin, HMG Co-A reductase inhibitors - CYP3A4 inhibitors]
[N05AL02, sultopride, QT prolonging agents - QT prolonging agents]
[G04BD05, terodiline, QT prolonging agents - QT prolonging agents]
[S01AA17, erythromycin, QT prolonging agents - QT prolonging agents]
[C01BD05, ibutilide, QT prolonging agents - QT prolonging agents]
[N05AE03, sertindole, QT prolonging agents - QT prolonging agents]
[R06AX11, astemizole, QT prolonging agents - QT prolonging agents]
[R06AX12, terfenadine, QT prolonging agents - QT prolonging agents]
[C01BC04, flecainide, QT prolonging agents - QT prolonging agents]
[J02AC01, fluconazole, QT prolonging agents - QT prolonging agents]
[C01BD04, dofetilide, QT prolonging agents - QT prolonging agents]
[P01BX01, halofantrine, QT prolonging agents - QT prolonging agents]
[N05AD01, haloperidol, QT prolonging agents - QT prolonging agents]
[L01CE02, irinotecan, Irinotecan - CYP3A4 inhibitors]
[P01BA02, hydroxychloroquine, QT prolonging agents - QT prolonging agents]
[H01BA04, terlipressin, QT prolonging agents - QT prolonging agents]
[M03BX02, tizanidine, Tizanidine - CYP 1A2 inhibitors]
[N05CH02, ramelteon, Ramelteon - specific CYP1A2 inhibitors]
[L01XX35, anagrelide, QT prolonging agents - QT prolonging agents]
[C10AA02, lovastatin, HMG Co-A reductase inhibitors - CYP3A4 inhibitors]
[N05AC03, mesoridazine, QT prolonging agents - QT prolonging agents]
[N07BC02, methadone, QT prolonging agents - QT prolonging agents]
[N05AA02, methotrimeprazine, QT prolonging agents - QT prolonging agents]
[S01AE05, levofloxacin, QT prolonging agents - QT prolonging agents]
[N05AG02, pimozide, QT prolonging agents - QT prolonging agents]
[J01MA11, grepafloxacin, QT prolonging agents - QT prolonging agents]
[C10AX02, probucol, QT prolonging agents - QT prolonging agents]
[C01BA02, procainamide, QT prolonging agents - QT prolonging agents]
[N01AX10, propofol, QT prolonging agents - QT prolonging agents]
[C01BA01, quinidine, QT prolonging agents - QT prolonging agents]
[J01FA06, roxithromycin, QT prolonging agents - QT prolonging agents]
[C07AA07, sotalol, QT prolonging agents - QT prolonging agents]
